Get my own profile
Public access
View all10 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Hans Bräuner-OsborneProfessor of Molecular Pharmacology, University of CopenhagenVerified email at sund.ku.dk
- Darryl Scott PickeringUniversity of CopenhagenVerified email at sund.ku.dk
- John ShelleySchrödinger Fellow, Schrödinger, Inc.Verified email at schrodinger.com
- Rasmus Prætorius ClausenUniversity of CopenhagenVerified email at sund.ku.dk
- Paul SanschagrinStrategic Deployment Manager, SchrodingerVerified email at schrodinger.com
- Kasper B. HansenAssociate Professor, University of MontanaVerified email at mso.umt.edu
- Ramy FaridSchrödinger, Inc.Verified email at schrodinger.com
- Michael GajhedeProfessor i proteinkrystallografi, Københavns UniversitetVerified email at sund.ku.dk
- Stine Byskov VogensenDepartment of Drug Design and Pharmacology, University of CopenhagenVerified email at sund.ku.dk
- Anuradha CholletiSchrodingerVerified email at schrodinger.com
- Mathew D. HallsSenior Vice President, Schrödinger Inc.Verified email at mhalls.com
- Anders Skov KristensenUniversity of CopenhagenVerified email at sund.ku.dk
- Graham JohnstonUniversity of SydneyVerified email at mail.usyd.edu.au
- Ivan Tubert-BrohmanSenior Staff Developer, SchrödingerVerified email at schrodinger.com
- Kai ZhuSenior Director at BeiGeneVerified email at beigene.com
- Jonas BoströmTreeline Biosciences,USVerified email at treeline.bio
- osman mirzaAssociate professor in Medicinal chemistryVerified email at sund.ku.dk
- Jesper L. KristensenUniversity of CopenhagenVerified email at sund.ku.dk
- Lars OlsenDepartment of Drug Design and Pharmacology, University of CopenhagenVerified email at novozymes.com
- Per-Ola NorrbyPrincipal Scientist, AstraZenecaVerified email at astrazeneca.com